Deal Spree Continues as Celgene Nabs Juno in $9B Deal Post author:Sam Post published:January 21, 2018 Post category:BioPharma The announcement sent shares of Juno soaring more than 27 percent in pre-market trading to $86.26. Source: BioSpace You Might Also Like Biotech Startup Formed by 4 Ex-Pfizer Employees Inks Deal With Former Employer January 22, 2018 Where High-Flying Cara Therapeutics Could be in 5 Years October 5, 2017 Ligand To Report First Quarter 2017 Results On May 9th April 12, 2017